Release not found

Name: PPN World global press-release archive
License: https://www.ppnworld.com/legal/press-content

This press release isn’t in the live store anymore. Open the original on the wire, or jump into the live feed.

Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC · PR Newswire (US) · PPN World